An experimental drug designed to treat patients with a specific kind of breast cancer known as HER2-positive appeared to boost survival compared to the standard treatment, a new study…

Doctors have successfully dropped the first “smart bomb” on breast cancer, using a drug to deliver a toxic payload to tumor cells while leaving healthy ones alone.

In a key test…

A novel form of trastuzumab (Herceptin) with chemotherapy attached appears to improve progression-free survival (PFS) in advanced HER2-positive breast cancer with a hint of survival benefit as well, a pivotal clinical…

Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is…

Women who regularly work into the early hours can be nearly four times as likely to develop breast cancer, scientist have warned.

The risk is highest among women who…

Interim results from a mid-stage trial of Celldex Therapeutics Inc’s experimental drug showed trends toward reducing tumors in patients with advanced breast cancer, with rates improving for those patients…

Magnetic resonance imaging (MRI) provides an indication of a breast tumor’s response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online in…

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms…

Millions of middle-aged women were needlessly denied HRT because a landmark report which found it raised the risk of breast cancer was exaggerated, while the benefits to middle-aged women were…

New research suggests that weight loss through exercise and dieting helps overweight women lower the levels of certain hormones in their blood, potentially raising the odds that they’ll…

Multiple research projects – including a 2006 study conducted at the University of North Carolina at Chapel Hill – have used DNA microarray analysis to identify several…

Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of…

The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central’s open access journal Breast Cancer Research.…

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and…

In two back-to-back reports published online on 17 May in Cell, researchers have sequenced the genomes of 21 breast cancers and analysed the mutations that emerged during the tumours’ development. The…

Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalogue of the mutations that accumulate in breast cells, raising hopes that the disease may be…

Chemotherapy is a major first line defense against breast cancer. However a patient’s response is often variable and unpredictable. A study published in BioMed Central’s open access journal BMC…

Barcelona, Spain: Using a concentrated, highly targeted dose of radiation to the breast has equally good results as irradiating the whole area, with no…

Physical activity is associated with reduced breast and colon cancer mortality, but there is insufficient evidence on the association for other cancer types, according to…

Researchers from the University of Adelaide are hoping to better understand why the mutated genes for breast and ovarian cancer are not passed on more frequently from one generation of…

Excellent treatment results testify to high quality of care at Heidelberg University Hospital’s Breast Center / First publication of prospectively collected data in Germany

How successful is the interdisciplinary treatment…

Breast cancer in young women is a biologically unique disease that requires customized management strategies, researchers report at the 4th IMPAKT Breast Cancer Conference, in Brussels, Belgium.

The reported…

An investigation published December 16th in the Journal of the National Cancer Institute reveals that over the last several years in the U.S., accelerated partial breast irradiation using…

Many women who were not ideal candidates for accelerated partial breast irradiation based on treatment guidelines regularly receive the treatment, according to a population-based study.

Between 2000 and 2007, 2.6% of…

Use of brachytherapy to treat breast cancer continues to increase despite unresolved questions about long-term outcomes, according to data presented here.

From 2001 through 2006, breast brachytherapy accounted for 5% of all…